Search Results - "Sawyer, Lynette"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function by Singh, Yasmin, Sawyer, Lynette S., Pinkoski, Linda S., Dupuis, Kent W., Hsu, Jocelyn C., Lin, Lily, Corash, Laurence

    Published in Transfusion (Philadelphia, Pa.) (01-07-2006)
    “…BACKGROUND:  The INTERCEPT Blood System, a photochemical treatment (PCT) process, has been developed to inactivate pathogens in platelet concen‐trates. These…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Photochemical inactivation of chikungunya virus in human apheresis platelet components by amotosalen and UVA light by Tsetsarkin, Konstantin A, Sampson-Johannes, Adam, Sawyer, Lynette, Kinsey, John, Higgs, Stephen, Vanlandingham, Dana L

    “…Chikungunya virus (CHIKV) is a mosquito-borne alphavirus that recently re-emerged in Africa and rapidly spread into countries of the Indian Ocean basin and…”
    Get full text
    Journal Article
  6. 6

    Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components by Grellier, Philippe, Benach, Jorge, Labaied, Mehdi, Charneau, Sébastien, Gil, Horacio, Monsalve, Gloria, Alfonso, Ryan, Sawyer, Lynette, Lin, Lily, Steiert, Matthias, Dupuis, Kent

    Published in Transfusion (Philadelphia, Pa.) (01-08-2008)
    “…BACKGROUND: Transfusion‐transmitted cases of malaria and babesiosis have been well documented. Current efforts to screen out contaminated blood products result…”
    Get full text
    Journal Article
  7. 7

    Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination by Sawyer, Lynette, Hanson, Deborah, Castro, Grace, Luckett, William, Dubensky Jr, Thomas W., Stassinopoulos, Adonis

    Published in Transfusion (Philadelphia, Pa.) (01-06-2007)
    “…BACKGROUND: The human erythrovirus B19 (B19) is a small (18‐ to 26‐nm) nonenveloped virus with a single‐stranded DNA genome of 5.6 kb. B19 is clinically…”
    Get full text
    Journal Article
  8. 8

    BLOOD COMPONENTS: Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function by Singh, Yasmin, Sawyer, Lynette S, Pinkoski, Linda S, Dupuis, Kent W, Hsu, Jocelyn C, Lin, Lily, Corash, Laurence

    Published in Transfusion (Philadelphia, Pa.) (01-07-2006)
    “…BACKGROUND:The INTERCEPT Blood System, a photochemical treatment (PCT) process, has been developed to inactivate pathogens in platelet concen-trates. These…”
    Get full text
    Journal Article
  9. 9

    Multicenter evaluation of the Bayer VERSANT™ HIV-1 RNA 3.0 assay: analytical and clinical performance by Gleaves, Curt A., Welle, John, Campbell, Mary, Elbeik, Tarek, Ng, Valerie, Taylor, Patricia E., Kuramoto, Ken, Aceituno, Sherri, Lewalski, Eva, Joppa, Barbara, Sawyer, Lynette, Schaper, Carl, McNairn, Denise, Quinn, Thomas

    Published in Journal of clinical virology (01-08-2002)
    “…Background: The use of quantitative HIV-1 RNA assays is part of the standard of care for the management of HIV-1-infected individuals. Objective: The Bayer…”
    Get full text
    Journal Article
  10. 10

    In vitro Evolution of a Neutralizing Human Antibody to Human Immunodeficiency Virus Type 1 to Enhance Affinity and Broaden Strain Cross-Reactivity by Barbas, Carlos F., Hu, Dana, Dunlop, Nancy, Sawyer, Lynette, Cababa, Doug, Hendry, R. Michael, Nara, Peter L., Burton, Dennis R.

    “…A method is described that allows for the improvement of antibody affinity. This method, termed complementary-determining region (CDR) walking, does not…”
    Get full text
    Journal Article
  11. 11

    Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated by SAWYER, L. S. W, WRIN, M. T, CRAWFORD-MIKSZA, L, POTTS, B, YAMING WU, WEBER, P. A, ALFONSO, R. D, HANSON, C. V

    Published in Journal of Virology (01-03-1994)
    “…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure by Ditzel, H J, Binley, J M, Moore, J P, Sodroski, J, Sullivan, N, Sawyer, L S, Hendry, R M, Yang, W P, Barbas, 3rd, C F, Burton, D R

    Published in The Journal of immunology (1950) (15-01-1995)
    “…As part of the goal of assembling a mixture of neutralizing human mAbs for possible prophylaxis and therapy of HIV-1 disease, we describe a strategy by which…”
    Get full text
    Journal Article
  14. 14

    Postexposure immunoprophylaxis of primary isolates by an antibody to HIV receptor complex by Wang, Chang Yi, Sawyer, Lynette S W, Murthy, Krishna K, Fang, Xinde

    “…mAB B4 is a monoclonal antibody directed against HIV receptor complex. The antibody had broad neutralizating activity against HIV and provided postexposure…”
    Get full text
    Journal Article
  15. 15

    Neutralizing antibody responses to autologous and heterologous isolates of human immunodeficiency virus by Wrin, T, Crawford, L, Sawyer, L, Weber, P, Sheppard, H W, Hanson, C V

    “…Although laboratory-adapted strains of human immunodeficiency virus (HIV) are generally highly sensitive to neutralization by HIV-positive patient sera, we…”
    Get more information
    Journal Article
  16. 16

    Mechanisms of the host cell effect on human immunodeficiency virus type 1 neutralization sensitivity by Sawyer, Lynette Susan Walker

    Published 01-01-1996
    “…Neutralizing antibody responses in vitro are a primary marker of host immunity and resistance to viral infection in vivo. However, studies of in vitro…”
    Get full text
    Dissertation